G21.1 Other drug-induced secondary parkinsonism

Name of the Condition

• Other drug-induced secondary parkinsonism

Summary

Other drug-induced secondary parkinsonism is a condition that mimics the symptoms of Parkinson's disease, such as tremors, rigidity, and slowed movement, but is caused by medications other than neuroleptics. It results from the use of drugs that interfere with dopamine pathways, leading to reduced dopamine activity in the brain.

Causes

This condition is caused by medications that block dopamine receptors or reduce dopamine production, including certain antiemetics, calcium channel blockers, or other drugs that affect neurotransmitter function. Unlike neuroleptic-induced parkinsonism, it excludes antipsychotic medications.

Risk Factors

• Use of dopamine-blocking medications (e.g., metoclopramide, prochlorperazine).
• Long-term or high-dose exposure to these drugs.
• Pre-existing susceptibility to dopamine-related side effects.
• Advanced age or underlying neurological conditions.

Symptoms

• Muscle stiffness or rigidity
• Tremors, often at rest
• Bradykinesia (slowed movement)
• Impaired balance and coordination
• Reduced facial expression (masked facies)
• Difficulty with fine motor tasks

Diagnosis

Diagnosis involves a thorough medical history review, including medication use, and a neurological examination to assess parkinsonian symptoms. Other causes of secondary parkinsonism must be ruled out, and medication history is critical to identifying the trigger.

Treatment Options

• Discontinuing or adjusting the offending medication if possible.
• Switching to alternative therapies with lower dopamine-blocking effects.
• Using medications to manage symptoms, such as levodopa or dopamine agonists.
• Monitoring for symptom improvement after medication changes.

Prognosis and Follow-Up

Prognosis is generally favorable if the causative drug is discontinued, with symptoms often improving over time. Follow-up includes monitoring for symptom resolution and avoiding re-exposure to the triggering medication. Long-term management may involve symptom control if discontinuation is not feasible.

Complications

• Persistent parkinsonian symptoms if the drug cannot be stopped.
• Increased risk of falls due to balance and movement issues.
• Reduced quality of life if symptoms are severe or prolonged.

Lifestyle & Prevention

• Avoiding or minimizing use of dopamine-blocking medications when possible.
• Regular monitoring of medication side effects.
• Physical therapy to maintain mobility and balance.
• Educating patients on recognizing early signs of parkinsonism.

When to Seek Professional Help

Seek medical attention if you experience new or worsening tremors, stiffness, or slowed movement, especially after starting a new medication. Prompt evaluation can help identify and address the cause early.

Tips for Medical Coders

Document the specific drug or class of drugs responsible for the parkinsonism, as this is critical for accurate coding. Ensure the medical record supports the temporal relationship between medication use and symptom onset. Include details on whether the medication was discontinued or adjusted, as this impacts coding and clinical management.